Back to Stocks

EXPO

EXPONENT INC
7 filings tracked
industrialsprofessional servicesSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Exponent is successfully pivoting from a traditional engineering consultancy to a critical strategic partner for the AI and climate adaptation economies.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline revenue growth, a closer look at the financials reveals a deteriorating operating engine.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every EXPO filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Exponent's first quarter presents a stark dichotomy between top-line growth and cash-flow sustainability. On one hand, the company is successfully capturing the 'AI tailwind,' with revenues climbing 14.3% and EBITDA margins expanding slightly. The growth in the Engineering and Other Scientific segment proves that the firm's specialized expertise remains in high demand as companies navigate complex technological and regulatory landscapes. However, the financial cost of this growth is evident in the negative operating cash flow and the rapid depletion of the balance sheet. The reliance on treasury stock purchases to inflate diluted EPS, combined with a slump in the Environmental and Health segment, suggests that the operational efficiency is not keeping pace with the scale. Investors must now weigh the ability of the firm to maintain its premium valuation against a shrinking cash runway and rising corporate overhead.

Selected Quarter

Core Takeaway

Exponent is growing its top line through high-tech consulting, but aggressive capital returns and rising costs are straining liquidity.

Investor Lens

The trade-off is between impressive top-line growth/AI positioning and a deteriorating cash-flow profile.

Watch Next

The next quarterly report's operating cash flow and the impact of the new $50M buyback authorization on liquidity.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.33Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%
bullishMay 8

Net income increased 11% to $29.6 million driven by strong top-line growth.

earnings beat
70%
bullishMay 8

EBITDA margin expanded to 28.4% from 27.3% due to higher billing rates.

margin expansion
40%
bullishMay 8

Aggressive return of capital with $78.8M in repurchases and a new $50M authorization.

buyback
80%
bearishMay 8

Total operating income fell 6.9% as compensation expenses surged 20.4%.

margin compression
60%

Filing History

10-QMay 8, 2026
Expand Sequence

Exponent's first quarter presents a stark dichotomy between top-line growth and cash-flow sustainability. On one hand, the company is successfully capturing the 'AI tailwind,' with revenues climbing 14.3% and EBITDA margins expanding slightly. The growth in the Engineering and Other Scientific segment proves that the firm's specialized expertise remains in high demand as companies navigate complex technological and regulatory landscapes. However, the financial cost of this growth is evident in the negative operating cash flow and the rapid depletion of the balance sheet. The reliance on treasury stock purchases to inflate diluted EPS, combined with a slump in the Environmental and Health segment, suggests that the operational efficiency is not keeping pace with the scale. Investors must now weigh the ability of the firm to maintain its premium valuation against a shrinking cash runway and rising corporate overhead.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.